ClinicalTrials.Veeva

Menu

Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy

Samsung Medical Center logo

Samsung Medical Center

Status

Enrolling

Conditions

Pediatric Cancer Patients

Treatments

Radiation: Proton therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02644993
2015-10-111

Details and patient eligibility

About

The study aim of this study is to evaluate the effect of proton therapy on quality of life and long-term normal tissue toxicities of the pediatric cancer patients. Based on these results, the predictive model of long-term normal tissue toxicities, survival, and quality of life could be recognized. Risk-adapted treatment strategy based on the predictive model in pediatric cancer patients could be established.

Enrollment

400 estimated patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • less than 18 years of age
  • patient who is planned to receive proton therapy at Samsung Medical Center
  • Informed consent

Exclusion criteria

  • Refuse to participate this cohort study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

400 participants in 1 patient group

Proton beam therapy
Experimental group
Treatment:
Radiation: Proton therapy

Trial contacts and locations

1

Loading...

Central trial contact

Jeong Il Yu, MD; Do Hoon Lim, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems